ARKG vs NOBL
ARK Genomic Revolution ETF vs ProShares S&P 500 Dividend Aristocrats ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
NOBL—
ProShares S&P 500 Dividend Aristocrats ETF
S&P 500 names with 25+ years of dividend growth.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | NOBL |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | ProShares |
ARKG top holdings
Holdings data unavailable for ARKG.
NOBL top holdings
Holdings data unavailable for NOBL.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About NOBL
NOBL (ProShares S&P 500 Dividend Aristocrats ETF) is S&P 500 names with 25+ years of dividend growth.